TNF and inflammatory bowel disease: According to the BSG and AGA, TNF antagonists, anti-integrin, anti-IL-12/23 and Janus kinase inhibitors should be initiated as monotherapy or continued as prescribed in patients with IBD without SARS-CoV-2 (29, 30).